NSN 6505-01-687-8205 · NIIN 016878205 · FSC 6505
NO DASHES 6505016878205
In Stock
TOCILIZUMAB INJECTION
Drugs and Biologicals
Technical characteristics
2 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| FEAT | SPECIAL FEATURES | ACTEMRA (TOCILIZUMAB) IS AN INTERLEUKIN-6 (IL-6) RECEPTOR ANTAGONIST INDICATED FOR THE TREATMENT OF RHEUMATOID ARTHRITIS, GIANT CELL ARTERITIS, POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS, SYSTEMIC JUVENILE ARTHRITIS, AND CYTOKINE RELEASE SYNDROME (CRS); INTRAVENOUS INFUSION ONLY AFTER DILUTION; 400MG/20ML; SINGLE-USE VIAL; DISCARD UNUSED PORTION; NO PRESERVATIVE; ACTEMRA (TOCILIZUMAB) INJECTION IS A PRESERVATIVE-FREE,STERILE CLEAR, COLORLESS TO PALE YELLOW SOLUTION. STORE AT 2 C TO 8 C (36 F TO 46 F). DO NOT FREEZE. |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | TOCILIZUMAB INJECTION, 400MG/20ML, ONE VIAL |